glp-1 benefits and risks Medications: Everything You Need to Know How Employers Can Optimize Benefits

Description

Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss

The people out there who are taking care of, you know, Vonda Wright, whos an orthopedic surgeon BB: Oh, love

Riot Platforms: A $311M AMD Deal Changes the HPC Game America's Weight-Loss Fixation Is Driving Massive Growth Industry consultancy firm Grand View Research forecasts the GLP-1 drug market to grow by a compound annual growth rate of 18.54% between 2024 and 2030, resulting in a global market value increase from $13.84 to $48.84 billion

What These Changes Mean for Med Spas and Weight Loss Clinics The changing regulatory environment may affect nearly every part of a GLP-1 weight loss program